Should you buy MEDIF stock?

Last updated:

Based on market data through , StockInvest.us rates Medipharm Labs Corp (MEDIF) as Hold/Accumulate with a technical score of 0.00 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Hold signal since
  • Price since signal Down 3.11%
  • 3-month trend forecast Down 10.87%
  • Hold/Accumulate 0.00
AI Analysis AI Analysis of MEDIF AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add MEDIF to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Medipharm Labs Corp stock price ended at $0.0519 on Monday, after losing 3.82%
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Hold candidate since Aug 04, 2026 Loss -3.11%

The Medipharm Labs Corp stock price fell by -3.82% on the last day (Monday, 10th Aug 2026) from $0.0540 to $0.0519. During the last trading day the stock fluctuated 8.20% from a day low at $0.0501 to a day high of $0.0542. The price has risen in 6 of the last 10 days but is still down by -3.82% for this period. Volume has increased on the last day by 436 shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 436 shares were bought and sold for approximately $22.64 .

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -10.87% during the next 3 months and, with a 90% probability hold a price between $0.0413 and $0.0532 at the end of this 3-month period.

MEDIF Signals & Forecast

There are few to no technical positive signals at the moment. The Medipharm Labs Corp stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $0.0534 and $0.0534. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, July 16, 2026, and so far it has fallen -15.83%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Medipharm Labs Corp gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Medipharm Labs Corp stock

Medipharm Labs Corp finds support from accumulated volume at $0.0513 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0041 between high and low, or 8.20%. For the last week, the stock has had daily average volatility of 5.34%.

Our recommended stop-loss: $0.0497 (-4.21%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 17 days ago.)

Trading Expectations (MEDIF) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Medipharm Labs Corp to open at $0.0521, and during the day (based on 14 day Average True Range), to move between $0.0503 and $0.0536, which gives a possible trading interval of +/-$0.0033 (+/-6.46%) up or down from last closing price. If Medipharm Labs Corp takes out the full calculated possible swing range there will be an estimated 6.46% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.0513 (1.22%) than the resistance at $0.0536 (3.21%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Medipharm Labs Corp will release earnings on Thursday, August 13, 2026.The consensus among the analysts for the expected earnings (EPS) is -$0.0019. We will update the financials statements for Medipharm Labs Corp, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 12.12% in the first trading day after earnings release.

Is Medipharm Labs Corp stock A Buy?

Medipharm Labs Corp holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $0.0521 ( 0.282%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

MEDIF Performance

Trading levels for MEDIF

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.0562 8.20%
R2 0.0546 5.17%
R1 0.0537 3.31%
Price 0.0519
S1 0.0505 -2.74%
S2 0.0495 -4.61%
S3 0.0480 -7.63%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.0635 22.19%
R2 0.0570 9.75%
R1 0.0536 3.21%
Price 0.0519
S1 0.0513 -1.22%
S2 0.0512 -1.34%
S3 0.0501 -3.57%

FAQ

What is the symbol for Medipharm Labs Corp Stock and on which exchange is it traded?
The symbol for Medipharm Labs Corp is MEDIF and it is traded on the OTCBB (OTC Bulletin Board).

Should I buy or sell Medipharm Labs Corp Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Medipharm Labs Corp (MEDIF) as Hold/Accumulate with a technical score of 0.00 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Hold signal began on Aug 04, 2026, the price has fallen 3.11%. The current 3-month trend forecast projects a fall of 10.87%.

How to buy Medipharm Labs Corp Stock?
Medipharm Labs Corp Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Medipharm Labs Corp Stock.

What's the current price of Medipharm Labs Corp Stock?
As of the end of day on the Aug 10, 2026, the price of an Medipharm Labs Corp (MEDIF) share was $0.0519.

What is the 52-week high and low for Medipharm Labs Corp Stock?
The 52-week high for Medipharm Labs Corp Stock is $0.0740 and the 52-week low is $0.0420.

What is the market capitalization of Medipharm Labs Corp Stock?
As of the Aug 10, 2026, the market capitalization of Medipharm Labs Corp is 22.065M.

When is the next earnings date for Medipharm Labs Corp?
The upcoming earnings date for Medipharm Labs Corp is Aug 13, 2026.
Click to get the best stock tips daily for free!
ABOUT MEDIPHARM LABS CORP
Medipharm Labs
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. The company also provides GMP flower sourcing, packaging, and distribution services. MediPharm Labs Corp. was founded in 2015 and is ...
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE